National Institute of Allergy and Infectious Diseases (U.S.)
"National Institute of Allergy and Infectious Diseases (U.S.)" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Component of the NATIONAL INSTITUTES OF HEALTH. It conducts and supports basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases. It was established in 1948.
| Descriptor ID |
D054579
|
| MeSH Number(s) |
I01.409.418.750.600.650.496.400 N03.540.052.750.400 N03.540.348.500.500.600.650.496.400
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "National Institute of Allergy and Infectious Diseases (U.S.)".
Below are MeSH descriptors whose meaning is more specific than "National Institute of Allergy and Infectious Diseases (U.S.)".
This graph shows the total number of publications written about "National Institute of Allergy and Infectious Diseases (U.S.)" by people in this website by year, and whether "National Institute of Allergy and Infectious Diseases (U.S.)" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2020 | 0 | 1 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "National Institute of Allergy and Infectious Diseases (U.S.)" by people in Profiles.
-
Analytical challenges in omics research on asthma and allergy: A National Institute of Allergy and Infectious Diseases workshop. J Allergy Clin Immunol. 2024 Apr; 153(4):954-968.
-
Clinical Research Needs for the Management of Chronic Rhinosinusitis with Nasal Polyps in the New Era of Biologics: A National Institute of Allergy and Infectious Diseases Workshop. J Allergy Clin Immunol Pract. 2020 05; 8(5):1532-1549.e1.
-
Antibacterial resistance leadership group: open for business. Clin Infect Dis. 2014 Jun; 58(11):1571-6.